Azenta, Inc. is a provider of life sciences solutions worldwide. The Company provides a full suite of cold-chain sample management solutions and multiomics services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's segments include Sample Management Solutions and Multiomics. Its Sample Management Solutions segment offers end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Company's Multiomics segment includes its genomic services business, which advances research and development activities by providing gene sequencing, synthesis, editing and related services. The Company's brands include GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey.
고수익 성장
회사의 순이익은 업계 선두를 달리고 있으며, 최근 연간 순이익은 미화 593.82M에 달합니다.
과대 평가된
회사의 최신 PE은 -7.47로, 최근 3년 기준 높은 백분위 범위에 속합니다.
기관 매도
최신 기관 보유 주식 수는 52.28M주이며, 전 분기 대비 8.52% 감소했습니다.
척 로이스가 보유
스타 투자자 척 로이스이(가) 이 주식 518.28K주를 보유하고 있습니다.
시장 활동 감소
회사는 투자자들의 관심이 줄어들어, 최근 20일간 회전율이 -0.25입니다.